The first biopsy revealed a usual form of pilomatricoma. Six months later, the lesion recurred, with a swift growth attaining 6 cm. The new biopsy showed a poorly circumscribed dermal tumor that composed of basaloid cell with focally pleomorphic nuclei and frequent mitoses. Some mitoses were atypical and there was significant mitotic activity (38 mitoses per 10 high-power fields). There was no connection to the epidermis. The center of the sheets contained rather abundant necrosis and areas of mummified cells leading to a diagnosis of malignant pilomatricoma, despite the lack of vascular invasion or perineural involvement (Figure 1, 2).
Figure 2: Foci of transitional cells and shadow cells (H&E x200).
An excision with a 1 cm wide margin was made. No inguinal lymphadenopathy was noticed. No event occurred up to now (2 years of follow-up).
Case 2: Ms F. 66 years, consulted her physician in March 2012 for a 1.5 cm nodule of the left upper eyelid, noticed for one month. On microscopy: there was malignant pilomatricoma, with a proliferation of atypical basaloid cells with numerous mitoses (Figure 3), tiny areas of necrosis and mummification. A wide excision with a security margin was performed, without a following event but a very short follow-up of several months only.
Figure 3: Hyperchromatic and pleomorphic basaloid cells, with abundant necrosis (H&E x200).
The clinical distinction between benign and malignant pilomatricoma is rather difficult (same presentation and same preferential cephalic localization)[4]. Macroscopically, the tumour shows a reddish, rather firm and lobulated aspect[4,5]. Histologically, it is a pilomatricoma with sheets of basaloid cells evolving towards mummification with sometimes calcifications. Malignancy is certain when the tumour has the following features: poor circumscription, nuclear atypia and atypical mitoses, areas of massive necrosis, infiltration of the hypodermis, dermis or cartilage with sometimes perineural and/or vascular invasion[3-10].
A distinct entity of pilomatricoma, called, ‘proliferating pilomatricoma’ or ‘atypical pilomatricoma’ has been proposed by Kaddu et al. in 1997[11,12]. This variant occurs mainly in middle-aged adults and the elderly[11,12] and to date, very few cases of proliferating pilomatricoma were described in the literature.
Morphologically, the proliferating pilomatricoma shows a relatively symmetric proliferation, constituted of basaloid lobules, more or less well outlined. The cells show nuclear atypia and mitotic activity ranging from 4 to 15 mitoses / high-power field. There is, however, no perineural and/or vascular invasion[11,12,13,15].
This entity is, in our opinion, very debatable, the absence of perineural and/or vascular invasion, does not exclude malignancy, even more such a brisk mitotic activity equates with malignancy. The distinction malignant versus proliferating pilomatricoma has no therapeutic implication, the treatment being the same, with a high risk of recurrence.
Malignant pilomatricoma is a low-grade malignant tumour, with local evolution and a high rate of recurrence in the absence of security margins (up to 50%)[4,6]. Nodal or systemic metastases are uncommon[6].
These risks determine the treatment. Despite the lack of consensus because of its rarity, most of the authors advocate removal with a safe margin of 0.5 to 1 cm[4,5,6]. Radiotherapy could be an alternative. Regular follow-up is then mandatory.
The origin of malignant pilomatricoma is still discussed: de novo or degenerating pilomatricoma? In the literature about 10 cases of malignant pilomatricomas have occurred on a classical pilomatricoma, sometimes after a very long latency of several decades, which could be construed as pleading for the second hypothesis[4,9].
In our first case, the very short delay is not in favor of degeneration, it was probably a bona fide malignant pilomatricoma, despite the fact that even retrospectively we could identify formal signs of malignancy. This observation incites to great caution in interpretation of histologic slides and underlines the difficulty of the diagnosis of malignant pilomatricoma.
In conclusion, malignant pilomatricoma is a rare tumour and difficult to diagnose. It must be distinguished from benign pilomatricoma on morphological arguments. A close follow-up of elderly patients after excision of a classical pilomatricoma in order to detect eventual recurrences is probably beneficial.
1) Malherbe A, Chenantais J. Note sur l’épithéliome calcifié des
glandes sébacées. Prog Med. 1880; 8:826–8.
2) Lopansri S, Mihm MC Jr. Pilomatrix carcinoma or calcifiyng
epitheliocarcinoma of Mahlerbe: A case report and review of the
literature. Cancer. 1980; 45:2368–73. [ Özet ]
3) Bremnes RM, Kvamme JM, Stalsberg H, Jacobsen EA. Pilomatrix
carcinoma with multiple metastases: Report of a case and review
of the literature. Eur J Cancer. 1999; 35:433–7. [ Özet ]
4) Hardisson D, Lineares MD, Cuevas-Santos J, Contreras F.
Pilomatrix carcinoma: A clinicopathologic study of six cases and
review of the literature. Am J Dermatopathol. 2001; 23:394–401. [ Özet ]
5) Petit T, Grossin M, Lefort E, Lamarche F, Hénin D. Pilomatrix
carcinoma: Histologic and immunohistochemical features. Two
studies. Ann Pathol. 2003; 23:50–4. [ Özet ]
6) Nieddermeyer HP, Peris K, Höfler H. Pilomatrix carcinoma with
multiple visceral metastases. Report of a case. Cancer. 1996;
77:1311–4. [ Özet ]
7) Schulz T. Pilomatrix carcinoma with metastasis. Am J
Dermatopathol. 2002; 24:525. [ Özet ]
8) Fujiwara T, Yamamoto H, Hashiro M. Malignant pilomatricoma.
Scand J Plast Reconstr Surg Hand Surg. 2002; 36:119–21. [ Özet ]
9) Marrogi AJ, Wick MR, Dehner LP. Pilomatrical neoplasms in
children and young adults. Am J Dermatopathol. 1992; 14:87–94. [ Özet ]
10) Sassmanshausen J, Chaffins M. Pilomatrix carcinoma: A report
of a case arising from a previously excised pilomatrixoma and
review of the literature. J Am Acad Dermatol. 2001; 44:358–61. [ Özet ]
11) Kaddu S, Soyer HP, Hödl S, Kerl H. Morphological stages of
pilomatricoma. Am J Dermatopathol. 1996; 18:333–8. [ Özet ]
12) Kaddu S, Soyer HP, Wolf IH, Kerl H. Proliferating pilomatricoma.
A histopathologic simulator of matrical carcinoma. J Cutan
Pathol. 1997; 24: 228–34. [ Özet ]
13) Hague JS, Maheshwari M, Ryatt KS, Abdullah A. Proliferating
pilomatricoma mimicking pyogenic granuloma. J Eur Acad
Dermatol. 2007; 21: 688-9. [ Özet ]
14) Sakai A, Maruyama Y, Hayashi A. Proliferating pilomatricoma: A
subset of pilomatricoma. J Plast Reconstr Aesthet Surg. 2008; 61:
811-4. [ Özet ]
15) Niiyama S, Amoh Y, Saito N, Takasu H, Katsuoka K. Proliferating
pilomatricoma. Eur J Dermatol. 2009; 19:188–9. [ Özet ]